venBio Global Strategic Fund L.P. 13D and 13G filings for Akero Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-07-08 3:54 pm Purchase |
2020-07-06 | 13D | Akero Therapeutics, Inc. AKRO |
venBio Global Strategic Fund L.P. | 3,033,552 10.600% |
3,033,552 (New Position) |
Filing |